Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

IF 44.7 1区医学 Q1 ONCOLOGY

Journal of Clinical Oncology Pub Date : 2026-10-01 Epub Date: 2026-06-03 DOI:10.1200/JCO-25-01896

Deborah B Doroshow, Ticiana A Leal, Saiama N Waqar, Hossein Borghaei, D Ross Camidge, Konstantin H Dragnev, Martin J Edelman, David R Gandara, David E Gerber, Jhanelle E Gray, Fred R Hirsch, Hatim Husain, David E Kozono, Natasha B Leighl, Bob T Li, Tianhong Li, Philip C Mack, Joel W Neal, Paul K Paik, Sandip P Patel, Jonathan W Riess, Mary W Redman, Karen L Reckamp

引用次数: 0

查看原文本刊更多论文

非小细胞肺癌临床试验对免疫检查点抑制剂治疗的耐药性：来自Lung- map研究者的观点

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Clinical Oncology 医学-肿瘤学

CiteScore

41.20

自引率

2.20%

发文量

8215

审稿时长

2 months

期刊介绍： The Journal of Clinical Oncology serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. In print and in electronic format, JCO strives to publish the highest quality articles dedicated to clinical research. Original Reports remain the focus of JCO, but this scientific communication is enhanced by appropriately selected Editorials, Commentaries, Reviews, and other work that relate to the care of patients with cancer.